用MR指纹对焦性肝病变的无对比剂和定量表征进行MR指纹检测

Shohei Fujita1, Katsuhiro Sano1, Gastao Cruz1

  • 1From the Departments of Radiology (S.F., K.S., H.K., A. Suzuki, K.Y., Y.M., T.A., I.F., W.U., K.K., R.K., S.A.), Human Pathology (Y.F.), Hepatobiliary-Pancreatic Surgery (A. Saiura), and Gastroenterology (K.I.), Juntendo University School of Medicine, 1-2-1 Hongo, Bunkyo, Tokyo 113-8421, Japan; Department of Radiology, The University of Tokyo, Tokyo, Japan (S.F., Y.M., O.A.); Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, England (G.C., C.V., R.B., C.P.); Department of Radiology, University of Michigan, Ann Arbor, Mich (G.C.); Department of MR Clinical Science, Philips Japan, Tokyo, Japan (M.Y.); School of Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.B., C.P.); and Millennium Institute for Intelligent Healthcare Engineering, Santiago, Chile (R.B., C.P.).

Radiology. Imaging cancer
|November 24, 2023
PubMed
概括

肝脏MR指纹 (MRF) 提供了可行的肝脏焦点病变的定量表征. 这种技术在区分良性病变和恶性病变方面表现出高的诊断性能,使得在一次采集中能够进行准确的诊断.